BPMC - Blueprint Medicines Corp
129.46
0.180 0.139%
Share volume: 2,980,995
Last Updated: 07-17-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$129.28
0.18
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 10-30-2024 | 02-13-2025 | 05-01-2025 | |
| Total revenue | 96.116 M | 138.157 M | 128.184 M | 146.367 M | 149.413 M | |
| Cost of revenue | 3.191 M | 7.593 M | 1.932 M | 7.447 M | 2.802 M | |
| Gross profit | 92.925 M | 130.564 M | 126.252 M | 138.920 M | 146.611 M | |
| 40.50% | -3.30% | 10.03% | 5.54% | |||
| Operating expenses | 171.748 M | 173.609 M | 175.226 M | 180.122 M | 187.697 M | |
| Selling general and admin | 83.557 M | 89.339 M | 89.926 M | 96.450 M | 95.807 M | |
| Research and development | 88.191 M | 84.270 M | 85.300 M | 83.672 M | 91.890 M | |
| Total expenses | 171.748 M | 173.609 M | 175.226 M | 180.122 M | 187.697 M | |
| 1.08% | 0.93% | 2.79% | 4.21% | |||
| Operating income | -78.823 M | -43.045 M | -48.974 M | -41.202 M | -41.086 M | |
| Ebit | -78.447 M | -43.046 M | -48.387 M | -41.202 M | 9.414 M | |
| Pretax income | 89.316 M | -49.892 M | -56.003 M | -49.284 M | 1.285 M | |
| -155.86% | 12.25% | -12.00% | -102.61% | |||
| Income tax | 180.000 K | 102.000 K | 273.000 K | 671.000 K | 789.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 89.136 M | -49.994 M | -56.276 M | -49.955 M | 496.000 K | |
| -156.09% | -12.57% | 11.23% | 100.99% |